R. Wood

First name
R.
Last name
Wood
Yang, J., Andersen, K. M., Rai, K. K., Tritton, T., Mugwagwa, T., Tsang, C., et al. (2023). Health Care Resource Utilization and Costs Associated With COVID-19 Among Pediatrics Managed in the Community or Hospital Setting in England: A Population-based Cohort Study. Pediatr Infect Dis J. http://doi.org/10.1097/inf.0000000000004213
Yang, J., Andersen, K. M., Rai, K. K., Tritton, T., Mugwagwa, T., Reimbaeva, M., et al. (2023). Healthcare resource utilisation and costs of hospitalisation and primary care among adults with COVID-19 in England: a population-based cohort study. Bmj Open, 13, e075495. http://doi.org/10.1136/bmjopen-2023-075495
Lohan, C., Coates, G., Clewes, P., Stevenson, H., Wood, R., Tritton, T., et al. (2023). Estimating the cost and epidemiology of mild to severe chronic pain associated with osteoarthritis in England: a retrospective analysis of linked primary and secondary care data. Bmj Open, 13, e073096. http://doi.org/10.1136/bmjopen-2023-073096
Coates, G., Clewes, P., Lohan, C., Stevenson, H., Wood, R., Tritton, T., et al. (2023). Chronic Low Back Pain with and without Concomitant Osteoarthritis: A Retrospective, Longitudinal Cohort Study of Patients in England. Int J Clin Pract, 2023, 5105810. http://doi.org/10.1155/2023/5105810
Requena, G., Czira, A., Banks, V., Wood, R., Tritton, T., Castillo, C., et al. (2023). Comparative Effectiveness of Umeclidinium/Vilanterol versus Indacaterol/Glycopyrronium on Moderate-to-Severe Exacerbations in Patients with Chronic Obstructive Pulmonary Disease in Clinical Practice in England. Int J Chron Obstruct Pulmon Dis, 18, 2039-2054. http://doi.org/10.2147/copd.s408688
Coates, G., Clewes, P., Lohan, C., Stevenson, H., Wood, R., Tritton, T., et al. (2023). Health economic impact of moderate-to-severe chronic pain associated with osteoarthritis in England: a retrospective analysis of linked primary and secondary care data. Bmj Open, 13, e067545. http://doi.org/10.1136/bmjopen-2022-067545
Requena, G., Czira, A., Banks, V., Wood, R., Tritton, T., Castillo, C. M., et al. (2023). Comparison of Rescue Medication Prescriptions in Patients with Chronic Obstructive Pulmonary Disease Receiving Umeclidinium/Vilanterol versus Tiotropium Bromide/Olodaterol in Routine Clinical Practice in England. Int J Chron Obstruct Pulmon Dis, 18, 1431-1444. http://doi.org/10.2147/copd.s411437
Czira, A., Requena, G., Banks, V., Wood, R., Tritton, T., Castillo, C. M., et al. (2023). Comparative Effectiveness of Umeclidinium/Vilanterol versus Inhaled Corticosteroid/Long-Acting β(2)-Agonist in Patients with Chronic Obstructive Pulmonary Disease in a Primary Care Setting in England. Int J Chron Obstruct Pulmon Dis, 18, 643-659. http://doi.org/10.2147/copd.s405498
Requena, G., Banks, V., Czira, A., Wood, R., Tritton, T., Wild, R., et al. (2023). Treatment Patterns, Healthcare Utilization and Clinical Outcomes of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting β(2)-Agonist/Long-Acting Muscarinic Antagonist Dual Therapy in Primary Care in England. Int J Chron Obstruct Pulmon Dis, 18, 231-245. http://doi.org/10.2147/copd.s389281
von Arx, L. B., Rachman, J., Webb, J., Casey, C., Patel, A., Diomatari, C., et al. (2023). Therapeutic inertia related to the injectable glucagon-like peptide-1 receptor agonists dulaglutide and semaglutide in patients with type 2 diabetes in UK primary care. Diabetes Obes Metab. http://doi.org/10.1111/dom.14985